976 - 1000 of 8808 Results
Title
Year
- Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activity2020RESTRICTEDTitle: Endogenous Rab29 does not impact basal or nigericin and monensin stimulated LRRK2 pathway activityJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier:Citation Count: 1
-
RESTRICTEDTitle: Novel therapeutic approaches to target neurodegenerationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/au.167164898.84768756Citation Count: 0
-
RESTRICTEDTitle: Ethical and Responsible Use of AI/ML in the Earth, Space, and Environmental SciencesJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.168132856.66485758Citation Count: 1
-
RESTRICTEDTitle: Journal Production Guidance for Software and Data CitationsJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.22541/essoar.167252601.17695321Citation Count: 0
-
RESTRICTEDTitle: Automatic Facial Landmark Localization in Clinical Populations - Improving Model Performance with a Small DatasetJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.21203/rs.3.rs-19405Citation Count: 3
-
RESTRICTEDTitle: Neurochemical biomarkers in the differential diagnosis of movement disordersJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 10Start Page: 1411End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.22510Citation Count: 43
- Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases2022RESTRICTEDTitle: Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseasesJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 1Start Page: 101478End Page: 101478Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2021.101478Best OA location URL: http://www.jbc.org/article/S0021925821012874/pdfCitation Count: 19
-
RESTRICTEDTitle: Involvement of dopaminergic signaling in the cross talk between the renin-angiotensin system and inflammationJournal Name: Seminars in ImmunopathologyPublisher: Springer Science and Business Media LLCVol: 42Issue #: 6Start Page: 681End Page: 696Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00281-020-00819-8Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00281-020-00819-8.pdfCitation Count: 10
-
RESTRICTEDTitle: Inflammation in Experimental Models of α‐SynucleinopathiesJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 37End Page: 49Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28264Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8115204Citation Count: 24
-
RESTRICTEDTitle: Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic EfficacyJournal Name:Publisher:Vol:Issue #:Start Page: 1306End Page: 1321Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsptsci.0c00162;Citation Count: 9
-
RESTRICTEDTitle: Application of deep learning in detecting neurological disorders from magnetic resonance images: a survey on the detection of Alzheimer’s disease, Parkinson’s disease and schizophreniaJournal Name: Brain InformaticsPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1186/s40708-020-00112-2Best OA location URL: https://braininformatics.springeropen.com/track/pdf/10.1186/s40708-020-00112-2Citation Count: 182
-
RESTRICTEDTitle: Commentary: Atypical, Early‐Onset Dystonia‐Parkinsonism with Oculogyric Crises and Anterior Horn Cell Disorder due to a Novel DJ ‐1 MutationJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13296;Citation Count: 1
-
RESTRICTEDTitle: Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational ModificationsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1210End Page: 1227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031210Best OA location URL: https://www.mdpi.com/2218-273X/5/3/1210/pdf?version=1435227112Citation Count: 12
-
RESTRICTEDTitle: The Effects of Physical Activity in Parkinson’s Disease: A ReviewJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 6Issue #: 4Start Page: 685End Page: 698Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160790Best OA location URL: https://europepmc.org/articles/pmc5088404?pdf=renderCitation Count: 138
-
RESTRICTEDTitle: High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson’s diseaseJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1186/s40478-021-01282-8;Citation Count: 68
-
RESTRICTEDTitle: Mitochondrial isolation: when size mattersJournal Name:Publisher:Vol:Issue #:Start Page: 226End Page: 226Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.12688/wellcomeopenres.16300.1;Citation Count: 3
-
RESTRICTEDTitle: Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and DevelopmentJournal Name:Publisher:Vol:Issue #:Start Page: 216847901881751End Page: 216847901881751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/2168479018817517;Citation Count: 21
-
RESTRICTEDTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name:Publisher:Vol:Issue #:Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866;Citation Count: 9
-
RESTRICTEDTitle: Preventing Parkinson’s Disease: An Environmental AgendaJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 1Start Page: 45End Page: 68Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212922Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212922?id=journal-of-parkinsons-disease%2Fjpd212922Citation Count: 58
-
RESTRICTEDTitle: Growth Factor Therapy for Parkinson’s Disease: Alternative Delivery SystemsJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s2Start Page: S229End Page: S236Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212662Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212662?id=journal-of-parkinsons-disease%2Fjpd212662Citation Count: 6
-
RESTRICTEDTitle: A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative StudiesJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 12Issue #: 6Start Page: 1703End Page: 1725Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212986Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212986?id=journal-of-parkinsons-disease%2Fjpd212986Citation Count: 5
-
RESTRICTEDTitle: Developing new treatments in partnership for primary mitochondrial disease: What does industry need from academics, and what do academics need from industry?Journal Name: Journal of Inherited Metabolic DiseasePublisher: WileyVol: 44Issue #: 2Start Page: 301End Page: 311Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/jimd.12326Citation Count: 2
-
RESTRICTEDTitle: Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysisJournal Name: ESC Heart FailurePublisher: WileyVol: 8Issue #: 6Start Page: 5466End Page: 5481Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ehf2.13648Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712892Citation Count: 16
-
RESTRICTEDTitle: “LRRK2: Autophagy and Lysosomal Activity”Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00498Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00498/pdfCitation Count: 84
-
RESTRICTEDTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 51